BriaCell Therapeutics Cor... (BCTX)
NASDAQ: BCTX
· Real-Time Price · USD
0.74
0.00 (0.14%)
At close: Aug 15, 2025, 3:59 PM
0.72
-2.70%
After-hours: Aug 15, 2025, 07:39 PM EDT
BriaCell Therapeutics Income Statement
Financials in USD. Fiscal
year is
August - July.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 5.18K | 10.34K | 15.53K | 20.62K | 20.61K | 20.6K | 20.49K | 15.4K | 15.06K | 14.75K | 14.47K | 14.47K | 14.32K | 14.17K | 14.06K | 14.06K | 9.37K | 4.69K |
Gross Profit | -67.06K | -72.24K | -77.4K | -82.58K | -20.62K | -20.61K | -20.6K | -20.49K | -15.4K | -15.06K | -14.75K | -14.47K | -14.47K | -14.32K | -14.17K | -14.06K | -14.06K | -9.37K | -4.69K |
Operating Income | -24.42M | -27.32M | -29.98M | -33.33M | -35.27M | -31.71M | -26.37M | -23.27M | -19.79M | -18.24M | -17.4M | -14.28M | -11.65M | -12.33M | -8.87M | -6.97M | -6M | -1.7M | -2.93M |
Interest Income | 86.51K | 75.49K | 110.25K | 288.02K | 496.79K | 734.67K | 893.67K | 891.21K | 764.79K | 547.29K | 318.78K | 136.73K | 114.93K | 78.98K | 66.9K | 60.59K | 28.37K | 28.33K | 28.33K |
Pretax Income | -19.64M | -11.72M | -16.72M | -4.93M | -6.1M | -12.69M | -1.37M | -8.44M | -6.02M | -11.14M | 37.36K | -26.39M | -25.35M | -12.38M | -23.55M | 3.99M | 3.16M | -298.71K | -1.72M |
Net Income | -19.43M | -11.59M | -16.6M | -4.79M | -6M | -12.61M | -13.19M | -20.3M | -17.88M | -23.01M | 37.36K | -26.39M | -29.11M | -16.15M | -27.31M | 461.26K | 3.39M | 439.99K | -984.59K |
Selling & General & Admin | 5.85M | 5.91M | 5.99M | 6.15M | 7.33M | 7.57M | 7.43M | 7.93M | 6.77M | 6.8M | 7.31M | 6.57M | 4.17M | -78.1K | -2M | -3.64M | -2.8M | -707.72K | -230.59K |
Research & Development | 18.57M | 21.41M | 23.98M | 27.18M | 27.94M | 24.14M | 18.94M | 15.34M | 13.04M | 9.18M | 7.84M | 5.46M | 2.59M | 2.59M | 971.17K | 212.37K | 212.4K | 211.29K | 1.04M |
Other Expenses | 1K | 849.25 | 1.7K | 582.25 | -988.75 | -904.97 | -823.84 | -767.23 | 1.67M | 1.67M | 1.67M | 1.67M | 4.23K | 4.26K | 7.5K | 7.2K | 5.22K | 5.22K | 1.54K |
Operating Expenses | 24.42M | 27.32M | 29.98M | 33.33M | 35.27M | 31.71M | 26.37M | 23.27M | 21.47M | 13.49M | 12.65M | 9.54M | 5.22M | 12.33M | 8.5M | 5.99M | 5.02M | 712.63K | 2.31M |
Interest Expense | 36.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 979.00 | 979.00 | 63.44K | 109.22K | 123.97K | 123.97K | 65.07K | 22.28K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.90 |
Cost & Expenses | 24.42M | 27.32M | 29.98M | 33.33M | 35.27M | 31.71M | 26.37M | 23.27M | 15.57M | 7.59M | 6.75M | 3.64M | 5.22M | 12.33M | 8.68M | 6.4M | 5.43M | 1.13M | 2.55M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 15.03M | 10.73M | 22.31M | 22.28M | 7.26M | 11.45M | -1.34M | 6.52M | 6.46M | 6.55M | 7.76M | -59.25K | -15.5K |
Shares Outstanding (Basic) | 3.74M | 2.7K | 1.76K | 1.13K | 1.06K | 1.06K | 805.00 | 1.04K | 1.02K | 1.03K | 1.03K | 908.00 | 1.02K | 19.44K | 1.01K | 795.00 | 316.00 | 51.00 | 51.00 |
Shares Outstanding (Diluted) | 3.74M | 2.7K | 1.78K | 1.19K | 1.06K | 1.06K | 1.11K | 1.06K | 1.03K | 1.03K | 1.03K | 1.03K | 1.02K | 1.23K | 1.01K | 795.72 | 316.27 | 51.46 | 51.63 |
EPS (Basic) | -10.99 | -7.13 | -17.99 | -5.63 | -7.22 | -15.85 | -16.88 | -26.15 | -23.71 | -29.87 | -1.11 | -33.2 | -57.9 | -33.87 | -53.21 | -30.53 | -28.73 | -54.75 | -88.01 |
EPS (Diluted) | -11.1 | -7.24 | -18.1 | -23.84 | -25.41 | -34.13 | -35.25 | -26.38 | -23.96 | -30.03 | -13.93 | -46.02 | -70.65 | -46.62 | -53.21 | -30.53 | -28.73 | -54.75 | -88.01 |
EBITDA | -24.13M | -27.19M | -29.87M | -33.25M | -29.97M | -26.41M | -21.07M | -17.97M | -31.3M | -31.75M | -16.1M | -38.23M | -25.29M | -16.14M | -27.5M | -368.25K | 1.83M | -1.69M | -2.92M |
EBIT | -24.28M | -27.32M | -29.98M | -33.33M | -29.98M | -26.43M | -21.09M | -17.98M | -31.31M | -31.77M | -16.12M | -38.25M | -25.3M | -16.16M | -27.51M | -383.69K | 1.81M | -1.7M | -2.93M |
Depreciation & Amortization | 152.41K | 129.57K | 106.74K | 83.9K | 15.27K | 15.27K | 15.27K | 15.27K | 15.27K | 15.27K | 15.27K | 16.25K | 16.24K | 17.11K | 17.1K | 16.12K | 16.15K | 14.51K | 14.22K |